Number of times cited according to CrossRef:

Lan Wang, Cui-Xia An, Mei Song, Na Li, Yuan-Yuan Gao, Xiao-Chuan Zhao, Lu-Lu Yu, Yu-Mei Wang, Xue-Yi Wang, Evaluation of childhood traumatic experience as a risk factor for alcohol use disorder in adulthood, BMC Psychiatry, 10.1186/s12888-020-2428-5, 20, 1,

Briana Lees, Lindsay R. Meredith, Anna E. Kirkland, Brittany E. Bryant, Lindsay M. Squeglia, Effect of alcohol use on the adolescent brain and behavior, Pharmacology Biochemistry and Behavior, 10.1016/j.pbb.2020.172906, (172906),

Dana E. Feldman, Katherine L. McPherson, Catherine L. Biesecker, Corinde E. Wiers, Peter Manza, Nora D. Volkow, Gene-Jack Wang, Neuroimaging of inflammation in alcohol use disorder: a review, Science China Information Sciences, 10.1007/s11432-019-2857-5, 63, 7,

Lorenzo Leggio, Daniel E. Falk, Megan L. Ryan, Joanne Fertig, Raye Z. Litten, Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies, Substance Use Disorders, 10.1007/164_2019_295, (443-462),

Pablo Berríos-Cárcamo, Mauricio Quezada, María Elena Quintanilla, Paola Morales, Marcelo Ezquer, Mario Herrera-Marschitz, Yedy Israel, Fernando Ezquer, Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules, Antioxidants, 10.3390/antiox9090830, 9, 9, (830),

Elizabeth M. Burnette, Wave-Ananda Baskerville, Erica N. Grodin, Lara A. Ray, Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial, Trials, 10.1186/s13063-020-04670-y, 21, 1,

Osvaldo Flores-Bastías, Alfredo Adriasola-Carrasco, Eduardo Karahanian, Activation of Melanocortin-4 Receptor Inhibits Both Neuroinflammation Induced by Early Exposure to Ethanol and Subsequent Voluntary Alcohol Intake in Adulthood in Animal Models: Is BDNF the Key Mediator?, Frontiers in Cellular Neuroscience, 10.3389/fncel.2020.00005, 14,

Santosh Kumar Prajapati, Shubham Bhaseen, Sairam Krishnamurthy, Alakh N. Sahu, Neurochemical Evidence of Preclinical and Clinical Reports on Target-Based Therapy in Alcohol Used Disorder, Neurochemical Research, 10.1007/s11064-019-02944-9,

Lara A. Ray, Erica N. Grodin, Lorenzo Leggio, Anita J. Bechtholt, Howard Becker, Sarah W. Feldstein Ewing, James David Jentsch, Andrea C. King, Barbara J. Mason, Stephanie O'Malley, James MacKillop, Markus Heilig, George F. Koob, The future of translational research on alcohol use disorder, Addiction Biology, 10.1111/adb.12903, 0, 0,

Sean P. Farris, Gayatri R. Tiwari, Olga Ponomareva, Marcelo F. Lopez, R. Dayne Mayfield, Howard C. Becker, Transcriptome Analysis of Alcohol Drinking in Non-Dependent and Dependent Mice Following Repeated Cycles of Forced Swim Stress Exposure, Brain Sciences, 10.3390/brainsci10050275, 10, 5, (275),

Jermaine D. Jones, Potential of Glial Cell Modulators in the Management of Substance Use Disorders, CNS Drugs, 10.1007/s40263-020-00721-9,

Maria Petralia, Emanuela Mazzon, Katia Mangano, Paolo Fagone, Roberto Di Marco, Luca Falzone, Maria Basile, Ferdinando Nicoletti, Eugenio Cavalli, Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders, Experimental and Therapeutic Medicine, 10.3892/etm.2020.8410,

Gregory Powell, Erin A. McClure, M. Foster Olive, Cassandra D. Gipson, Clinical Treatment of Addictive Disorders with N-Acetylcysteine, The Therapeutic Use of N-Acetylcysteine (NAC) in Medicine, 10.1007/978-981-10-5311-5, (219-233),

Milky Kohno, Jeanne Link, Laura E. Dennis, Holly McCready, Marilyn Huckans, William F. Hoffman, Jennifer M. Loftis, Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies, Pharmacology Biochemistry and Behavior, 10.1016/j.pbb.2019.01.007,

Jennifer K. Melbourne, K. Ryan Thompson, Hui Peng, Kimberly Nixon, Its complicated: The relationship between alcohol and microglia in the search for novel pharmacotherapeutic targets for alcohol use disorders, , 10.1016/bs.pmbts.2019.06.011,

María Elena Quintanilla, Fernando Ezquer, Paola Morales, Daniela Santapau, Pablo Berríos-Cárcamo, Marcelo Ezquer, Mario Herrera-Marschitz, Yedy Israel, Intranasal mesenchymal stem cell secretome administration markedly inhibits alcohol and nicotine self-administration and blocks relapse-intake: mechanism and translational options, Stem Cell Research & Therapy, 10.1186/s13287-019-1304-z, 10, 1,

Yedy Israel, María Elena Quintanilla, Fernando Ezquer, Paola Morales, Daniela Santapau, Pablo Berríos‐Cárcamo, Marcelo Ezquer, Belen Olivares, Mario Herrera‐Marschitz, Aspirin and N‐acetylcysteine co‐administration markedly inhibit chronic ethanol intake and block relapse binge drinking: Role of neuroinflammation‐oxidative stress self‐perpetuation, Addiction Biology, 10.1111/adb.12853, 0, 0,

K. E. Linker, S. J. Cross, F. M. Leslie, Glial mechanisms underlying substance use disorders, European Journal of Neuroscience, 10.1111/ejn.14163, 50, 3, (2574-2589),

Emma K. Erickson, Emily K. Grantham, Anna S. Warden, R. Adron Harris, Neuroimmune signaling in alcohol use disorder, Pharmacology Biochemistry and Behavior, 10.1016/j.pbb.2018.12.007,

Sarah S Ch’Ng, Andrew J Lawrence, Investigational drugs for alcohol use disorders: a review of preclinical data, Expert Opinion on Investigational Drugs, 10.1080/13543784.2018.1472763, 27, 5, (459-474),

Antonia M. Savarese, Amy W. Lasek, Transcriptional Regulators as Targets for Alcohol Pharmacotherapies, , 10.1007/164_2018_101,

Mark Egli, Advancing Pharmacotherapy Development from Preclinical Animal Studies, , 10.1007/164_2017_85,

Leon G. Coleman, Fulton T. Crews, Innate Immune Signaling and Alcohol Use Disorders, , 10.1007/164_2018_92,

Yuri A. Blednov, Adriana J. Da Costa, Tamara Tarbox, Olga Ponomareva, Robert O. Messing, R. Adron Harris, Apremilast Alters Behavioral Responses to Ethanol in Mice: I. Reduced Consumption and Preference, Alcoholism: Clinical and Experimental Research, 10.1111/acer.13616, 42, 5, (926-938),

Rui-Ting Wen, Fang-Fang Zhang, Han-Ting Zhang, Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder, Psychopharmacology, 10.1007/s00213-018-4895-7, 235, 6, (1793-1805),

Jing Shi, Huaxia Liu, Jianchun Pan, Jie Chen, Nianping Zhang, Kaiping Liu, Ning Fei, James M. O’Donnell, Han-Ting Zhang, Ying Xu, Inhibition of phosphodiesterase 2 by Bay 60-7550 decreases ethanol intake and preference in mice, Psychopharmacology, 10.1007/s00213-018-4934-4,

Laura B. Ferguson, R. Adron Harris, Roy Dayne Mayfield, From gene networks to drugs: systems pharmacology approaches for AUD, Psychopharmacology, 10.1007/s00213-018-4855-2,

Yousef Tizabi, Bruk Getachew, Clifford L. Ferguson, Antonei B. Csoka, Karl M. Thompson, Alejandra Gomez-Paz, Jana Ruda-Kucerova, Robert E. Taylor, Low Vs. High Alcohol: Central Benefits Vs. Detriments, Neurotoxicity Research, 10.1007/s12640-017-9859-x,

Fernando Ezquer, María Elena Quintanilla, Paola Morales, Marcelo Ezquer, Carolyne Lespay‐Rebolledo, Mario Herrera‐Marschitz, Yedy Israel, Activated mesenchymal stem cell administration inhibits chronic alcohol drinking and suppresses relapse‐like drinking in high‐alcohol drinker rats, Addiction Biology, 10.1111/adb.12572, 24, 1, (17-27),

Wadad Saba, Sébastien Goutal, Sylvain Auvity, Bertrand Kuhnast, Christine Coulon, Virginie Kouyoumdjian, Irène Buvat, Claire Leroy, Nicolas Tournier, Imaging the neuroimmune response to alcohol exposure in adolescent baboons: a TSPO PET study using 18F‐DPA‐714, Addiction Biology, 10.1111/adb.12548, 23, 5, (1000-1009),

Xin Liu, Pi-Da Hao, Ming-Feng Yang, Jing-Yi Sun, Lei-Lei Mao, Cun-Dong Fan, Zong-Yong Zhang, Da-Wei Li, Xiao-Yi Yang, Bao-Liang Sun, Han-Ting Zhang, The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice, Psychopharmacology, 10.1007/s00213-017-4631-8, 234, 16, (2409-2419),

Richard L. Bell, Sheketha R. Hauser, Tiebing Liang, Youssef Sari, Antoniette Maldonado-Devincci, Zachary A. Rodd, Rat animal models for screening medications to treat alcohol use disorders, Neuropharmacology, 10.1016/j.neuropharm.2017.02.004, 122, (201-243),

Mei-Fang Gong, Rui-Ting Wen, Ying Xu, Jian-Chun Pan, Ning Fei, Yan-Meng Zhou, Jiang-Ping Xu, Jian-Hui Liang, Han-Ting Zhang, Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents, Psychopharmacology, 10.1007/s00213-017-4697-3, 234, 20, (3143-3151),

Rui-Ting Wen, Jian-Hui Liang, Han-Ting Zhang, Targeting Phosphodiesterases in Pharmacotherapy for Substance Dependence, Phosphodiesterases: CNS Functions and Diseases, 10.1007/978-3-319-58811-7_15, (413-444),

J. Brandon Birath, Marisa Briones, Stephanie Amaya, Steven Shoptaw, Aimee-Noelle Swanson, John Tsuang, Benjamin Furst, Keith Heinzerling, Lisa Obermeit, Lauryn Maes, Charles McKay, Matthew J. Wright, Ibudilast may improve attention during early abstinence from methamphetamine, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2017.05.016, 178, (386-390),

Ashley M. Barajaz, Christopher L. Kliethermes, An assessment of the utilization of the preclinical rodent model literature in clinical trials of putative therapeutics for the treatment of alcohol use disorders, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2017.09.022, 181, (77-84),

Raye Z. Litten, Daniel E. Falk, Megan L. Ryan, Joanne Fertig, Lorenzo Leggio, Advances in Pharmacotherapy Development: Human Clinical Studies, , 10.1007/164_2017_79,

Alfredo Oliveros, Doo‐Sup Choi, Repurposing Tigecycline for the Treatment of Alcohol Use Disorder, Alcoholism: Clinical and Experimental Research, 10.1111/acer.13312, 41, 3, (497-500),

Marisa Roberto, Reesha R. Patel, Michal Bajo, Ethanol and Cytokines in the Central Nervous System, , 10.1007/164_2017_77,

Lara A Ray, Spencer Bujarski, Steve Shoptaw, Daniel JO Roche, Keith Heinzerling, Karen Miotto, Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial, Neuropsychopharmacology, 10.1038/npp.2017.10, 42, 9, (1776-1788),

Fulton T. Crews, Colleen J. Lawrimore, T. Jordan Walter, Leon G. Coleman, The role of neuroimmune signaling in alcoholism, Neuropharmacology, 10.1016/j.neuropharm.2017.01.031, 122, (56-73),

Ryan K. Bachtell, Jermaine D. Jones, Keith G. Heinzerling, Patrick M. Beardsley, Sandra D. Comer, Glial and neuroinflammatory targets for treating substance use disorders, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2017.08.003, 180, (156-170),

S. Alex Marshall, Kyle H. McKnight, Allyson K. Blose, Donald T. Lysle, Todd E. Thiele, Modulation of Binge-like Ethanol Consumption by IL-10 Signaling in the Basolateral Amygdala, Journal of Neuroimmune Pharmacology, 10.1007/s11481-016-9709-2, 12, 2, (249-259),

Jonathan Henry W Jacobsen, Mark R Hutchinson, Sanam Mustafa, Drug addiction: targeting dynamic neuroimmune receptor interactions as a potential therapeutic strategy, Current Opinion in Pharmacology, 10.1016/j.coph.2015.10.010, 26, (131-137),

Christopher M. Olsen, Qing-Song Liu, Phosphodiesterase 4 inhibitors and drugs of abuse: current knowledge and therapeutic opportunities, Frontiers in Biology, 10.1007/s11515-016-1424-0, 11, 5, (376-386),

H.C. Becker, M.F. Lopez, An Animal Model of Alcohol Dependence to Screen Medications for Treating Alcoholism, Animal Models for Medications Screening to Treat Addiction, 10.1016/bs.irn.2016.02.006, (157-177),

Ryan S. Poland, Yun K. Hahn, Pamela E. Knapp, Patrick M. Beardsley, M. Scott Bowers, Ibudilast attenuates expression of behavioral sensitization to cocaine in male and female rats, Neuropharmacology, 10.1016/j.neuropharm.2016.06.024, 109, (281-292),

M. Bajo, S. E. Montgomery, L. N. Cates, T. Nadav, A. M. Delucchi, K. Cheng, H. Yin, E. F. Crawford, A. J. Roberts, M. Roberto, Evaluation of TLR4 Inhibitor, T5342126, in Modulation of Ethanol-Drinking Behavior in Alcohol-Dependent Mice, Alcohol and Alcoholism, 10.1093/alcalc/agw026, 51, 5, (541-548),

Anna Warden, Emma Erickson, Gizelle Robinson, R Adron Harris, R Dayne Mayfield, The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies, Pharmacogenomics, 10.2217/pgs-2016-0062, 17, 18, (2081-2096),

Matthew J. Worley, Keith G. Heinzerling, Daniel J.O. Roche, Steve Shoptaw, Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2016.02.036, 162, (245-250),

M. D. Scofield, J. A. Heinsbroek, C. D. Gipson, Y. M. Kupchik, S. Spencer, A. C. W. Smith, D. Roberts-Wolfe, P. W. Kalivas, The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis, Pharmacological Reviews, 10.1124/pr.116.012484, 68, 3, (816-871),

Dorit Ron, Segev Barak, Molecular mechanisms underlying alcohol-drinking behaviours, Nature Reviews Neuroscience, 10.1038/nrn.2016.85, 17, 9, (576-591),

Susan E. Bergeson, Michelle A. Nipper, Jeremiah Jensen, Melinda L. Helms, Deborah A. Finn, Tigecycline Reduces Ethanol Intake in Dependent and Nondependent Male and Female C57BL/6J Mice, Alcoholism: Clinical and Experimental Research, 10.1111/acer.13251, 40, 12, (2491-2498),

Jorge Montesinos, Silvia Alfonso‐Loeches, Consuelo Guerri, Impact of the Innate Immune Response in the Actions of Ethanol on the Central Nervous System, Alcoholism: Clinical and Experimental Research, 10.1111/acer.13208, 40, 11, (2260-2270),

Raye Z. Litten, Daniel E. Falk, Megan L. Ryan, Joanne B. Fertig, Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development, Alcoholism: Clinical and Experimental Research, 10.1111/acer.13093, 40, 7, (1368-1379),

R.L. Bell, S. Hauser, Z.A. Rodd, T. Liang, Y. Sari, J. McClintick, S. Rahman, E.A. Engleman, A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction, Animal Models for Medications Screening to Treat Addiction, 10.1016/bs.irn.2016.02.017, (179-261),

Fulton T. Crews, Ryan P. Vetreno, Mechanisms of neuroimmune gene induction in alcoholism, Psychopharmacology, 10.1007/s00213-015-3906-1, 233, 9, (1543-1557),

Hermann A.M. Mucke, Drug Repurposing Patent Applications January–March 2015, ASSAY and Drug Development Technologies, 10.1089/adt.2015.29017.patdrrr, 13, 6, (332-337),

Marian L. Logrip, Phosphodiesterase regulation of alcohol drinking in rodents, Alcohol, 10.1016/j.alcohol.2015.03.007, 49, 8, (795-802),

Kelle M. Franklin, Sheketha R. Hauser, Amy W. Lasek, Jeanette McClintick, Zheng-Ming Ding, William J. McBride, Richard L. Bell, Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4), Psychopharmacology, 10.1007/s00213-014-3852-3, 232, 13, (2251-2262),

Manoranjan S. D'Souza, Glutamatergic transmission in drug reward: implications for drug addiction, Frontiers in Neuroscience, 10.3389/fnins.2015.00404, 9,

Maha Elsayed, Pierre J. Magistretti, A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue, Frontiers in Cellular Neuroscience, 10.3389/fncel.2015.00468, 9,

Changhai Cui, David Shurtleff, R. Adron Harris, Neuroimmune Mechanisms of Alcohol and Drug Addiction, Neuroimmune Signaling in Drug Actions and Addictions, 10.1016/B978-0-12-801284-0.00001-4, (1-12),